| Refractory cytopenia of childhood | |
|---|---|
| Other names | RCC |
Refractory cytopenia of childhood is a subgroup of myelodysplastic syndrome (MDS), having been added to the World Health Organization classification in 2008. Before then, RCC cases were classified as childhood aplastic anemia. RCC is the most common form of MDS in children and adolescents, accounting for approximately half of all MDS cases.
Presentation
Symptoms result from underproduction of red blood cells (weakness, pallor, failure to thrive, pica), white blood cells (recurrent or overwhelming infection), and/or platelets (bleeding).
Histopathologic features
The bone marrow of patients with RCC contains islands of erythroid precursors and spare granulocytes. In some scenarios, multiple bone marrow biopsy examinations may be recommended before a diagnosis can be established.
Diagnosis
 | This section is empty. You can help by adding to it. (November 2021) |
Management
Bone marrow transplant is the only known curative treatment.
References
- Niemeyer, C. M.; Baumann, I (2011). "Classification of childhood aplastic anemia and myelodysplastic syndrome". Hematology. 2011: 84–9. doi:10.1182/asheducation-2011.1.84. PMID 22160017.
- "Medscape Pediatric Myelodysplasia". Retrieved 16 June 2015.
- Niemeyer, C. M.; Baumann, I (2008). "Myelodysplastic syndrome in children and adolescents". Seminars in Hematology. 45 (1): 60–70. doi:10.1053/j.seminhematol.2007.10.006. PMID 18179970.